Inventor · disambiguated record
David Strayer
Also filed as: STRAYER DAVID · STRAYER DAVID R
11 granted patents·23 pending applications·29 citations·filing 2002–2022
85Inventor score
Files withAIM IMMUNOTECH INC14CARTER WILLIAM A8HEMISPHERX BIOPHARMA6HEMISPHERX BIOPHARMA INC4STRAYER DAVID1
Top patents by PatentIndex Score
34 records- 0191US9315538B2Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityHEMISPHERX BIOPHARMA INC·Filed 2014·Granted Apr 19, 2016·11 cites·13 claims
- 0290US8722874B2Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityCARTER WILLIAM A·Filed 2011·Granted May 13, 2014·9 cites·4 claims
- 0383US7943147B2dsRNAs as influenza virus vaccine adjuvants or immuno-stimulantsHEMISPHERX BIOPHARMA·Filed 2006·Granted May 17, 2011·7 cites·4 claims
- 0479US8075877B2Broad spectrum immune and antiviral gene modulation by oral interferonCARTER WILLIAM A·Filed 2007·Granted Dec 13, 2011·1 cites·17 claims
- 0579US7678774B2Treating severe acute respiratory syndromeHEMISPHERX BIOPHARMA·Filed 2007·Granted Mar 16, 2010·1 cites·12 claims
- 0664US11813279B2Compositions for cancer therapy and methodsAIM IMMUNOTECH INC·Filed 2019·Granted Nov 14, 2023·0 cites·29 claims
- 0761US11642396B2Method of reducing antigenic drift or reassortment of viruses in a host animal using α interferonAIM IMMUNOTECH INC·Filed 2014·Granted May 9, 2023·0 cites·6 claims
- 0861US2010160413A1Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityHEMISPHERX BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 0958US8075878B2Broad spectrum immune and antiviral gene modulation by oral interferonCARTER WILLIAM A·Filed 2007·Granted Dec 13, 2011·0 cites·19 claims
- 1058US2005137154A1Treating server acute respiratory syndromeHEMISPHERX BIOPHARMA·Filed 2004·Application pending·0 cites
- 1158US2024376481A1Compositions and methods for enhancing and expanding infection induced immunityAIM IMMUNOTECH INC·Filed 2022·Application pending·0 cites
- 1257US2015064216A1Dsrnas as influenza virus vaccine adjuvants or immuno-stimulantsHEMISPHERX BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 1357US2024350527A1Compositions and methods for treating post-covid conditions of fatigueAIM IMMUNOTECH INC·Filed 2022·Application pending·0 cites
- 1457US2014335112A1Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityHEMISPHERX BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 1556US2021196744A1Compositions for cancer therapy and methodsAIM IMMUNOTECH INC·Filed 2021·Application pending·0 cites
- 1652US2009304630A1Treating severe and acute viral infectionsHEMISPHERX BIOPHARMA·Filed 2007·Application pending·0 cites
- 1751US2011196020A1Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)CARTER WILLIAM A·Filed 2009·Application pending·0 cites
- 1851US2024218373A1Methods and compositions for treating neuroinflammationAIM IMMUNOTECH INC·Filed 2022·Application pending·0 cites
- 1950US2010310600A1Selective agonist of toll-like receptor 3CARTER WILLIAM A·Filed 2009·Application pending·0 cites
- 2050US2011044946A1Genetec regulation of host defense mechanisms by mucosal exposure to natural interferon alpha speciesCARTER WILLIAM A·Filed 2009·Application pending·0 cites
- 2150US2022387472A1Compositions and methods for treating cancerAIM IMMUNOTECH INC·Filed 2021·Application pending·0 cites
- 2250US2005070489A1Use of dsrnas in strategic therapeutic intervention of highly active antiretroviral therapyFiled 2002·Application pending·0 cites
- 2349US11813281B2Methods for improving exercise tolerance in myalgic encephalomyelitis patientsAIM IMMUNOTECH INC·Filed 2019·Granted Nov 14, 2023·0 cites·16 claims
- 2448US12102649B2Methods and compositions for treating endometriosisAIM IMMUNOTECH INC·Filed 2020·Granted Oct 1, 2024·0 cites·19 claims
- 2548US2006035859A1Treating severe and acute viral infectionsHEMISPHERX BIOPHARMA·Filed 2005·Application pending·0 cites
- 2648US2022096518A1Compositions and methods for cancer therapyAIM IMMUNOTECH INC·Filed 2019·Application pending·0 cites
- 2748US2010104533A1Early intervention of viral infection with immune activatorsCARTER WILLIAM A·Filed 2008·Application pending·0 cites
- 2848US2022356476A1Compositions and methods useful for ebola virus infectionAIM IMMUNOTECH INC·Filed 2020·Application pending·0 cites
- 2948US2011223198A1dsRNAs as influenza virus vaccine adjuvants or immuno-stimulantsHEMISPHERX BIOPHARMA·Filed 2011·Application pending·0 cites
- 3047US2022280547A1Compositions and methods for treating long covidAIM IMMUNOTECH INC·Filed 2022·Application pending·0 cites
- 3144US2014170191A1Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityCARTER WILLIAM A·Filed 2013·Application pending·0 cites
- 3240US12312376B2Therapeutic double stranded RNA and methods for producing the sameAIM IMMUNOTECH INC·Filed 2021·Granted May 27, 2025·0 cites·8 claims
- 3340US2012004290A1Treating chronic fatigue syndrome and prolonged qt intervalSTRAYER DAVID·Filed 2010·Application pending·0 cites
- 3440US2022380769A1Methods, compositions, and vaccines for treating a virus infectionAIM IMMUNOTECH INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Strayer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →